Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue 1.4 Market Analysis by Type 1.4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Lung Cancer 1.4.3 Colorectal Cancer 1.4.4 Breast Cancer 1.4.5 Others 1.5 Market by Application 1.5.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Research Institutes and Research Institutions 1.5.4 Clinic 1.5.5 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Perspective (2015-2026) 2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Growth Trends by Regions 2.2.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Share by Regions (2015-2020) 2.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Growth Strategy 2.3.6 Primary Interviews with Key Epidermal Growth Factor Receptor (EGFR) Inhibitor Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Market Size 3.1.1 Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Revenue (2015-2020) 3.1.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Players (2015-2020) 3.1.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Concentration Ratio 3.2.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in 2019 3.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players Head office and Area Served 3.4 Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Solution and Service 3.5 Date of Enter into Epidermal Growth Factor Receptor (EGFR) Inhibitor Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Size by Type (2015-2020) 4.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Type (2021-2026) 5 Epidermal Growth Factor Receptor (EGFR) Inhibitor Breakdown Data by Application (2015-2026) 5.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) 5.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2015-2020) 6.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in North America (2019-2020) 6.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) 6.4 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) 7 Europe 7.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2015-2020) 7.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in Europe (2019-2020) 7.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) 7.4 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) 8 China 8.1 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2015-2020) 8.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in China (2019-2020) 8.3 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) 8.4 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) 9 Japan 9.1 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2015-2020) 9.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in Japan (2019-2020) 9.3 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) 9.4 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2015-2020) 10.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) 10.4 Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) 11 India 11.1 India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2015-2020) 11.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in India (2019-2020) 11.3 India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) 11.4 India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2015-2020) 12.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in Central & South America (2019-2020) 12.3 Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) 12.4 Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Amgen Inc. 13.1.1 Amgen Inc. Company Details 13.1.2 Amgen Inc. Business Overview and Its Total Revenue 13.1.3 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction 13.1.4 Amgen Inc. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020)) 13.1.5 Amgen Inc. Recent Development 13.2 AstraZeneca Plc 13.2.1 AstraZeneca Plc Company Details 13.2.2 AstraZeneca Plc Business Overview and Its Total Revenue 13.2.3 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction 13.2.4 AstraZeneca Plc Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) 13.2.5 AstraZeneca Plc Recent Development 13.3 Eli Lilly and Co. 13.3.1 Eli Lilly and Co. Company Details 13.3.2 Eli Lilly and Co. Business Overview and Its Total Revenue 13.3.3 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction 13.3.4 Eli Lilly and Co. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) 13.3.5 Eli Lilly and Co. Recent Development 13.4 F. Hoffmann-La Roche Ltd. 13.4.1 F. Hoffmann-La Roche Ltd. Company Details 13.4.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue 13.4.3 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction 13.4.4 F. Hoffmann-La Roche Ltd. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) 13.4.5 F. Hoffmann-La Roche Ltd. Recent Development 13.5 Novartis AG 13.5.1 Novartis AG Company Details 13.5.2 Novartis AG Business Overview and Its Total Revenue 13.5.3 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction 13.5.4 Novartis AG Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) 13.5.5 Novartis AG Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Market Segments Table 2. Key Players Covered: Ranking by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Table 3. Ranking of Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Lung Cancer Table 6. Key Players of Colorectal Cancer Table 7. Key Players of Breast Cancer Table 8. Key Players of Others Table 9. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Regions (2015-2020) Table 13. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Growth Strategy Table 19. Main Points Interviewed from Key Epidermal Growth Factor Receptor (EGFR) Inhibitor Players Table 20. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Players (2015-2020) (Million US$) Table 21. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Players (2015-2020) Table 22. Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor as of 2019) Table 23. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Solution and Service Table 26. Date of Enter into Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) (Million US$) Table 29. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Type (2015-2020) Table 30. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Type (2021-2026) Table 31. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Application (2015-2020) Table 32. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) (Million US$) Table 33. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Application (2021-2026) Table 34. North America Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (2019-2020) (Million US$) Table 35. North America Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2019-2020) Table 36. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) (Million US$) Table 37. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2015-2020) Table 38. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) (Million US$) Table 39. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2015-2020) Table 40. Europe Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (2019-2020) (Million US$) Table 41. Europe Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2019-2020) Table 42. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) (Million US$) Table 43. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2015-2020) Table 44. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) (Million US$) Table 45. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2015-2020) Table 46. China Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (2019-2020) (Million US$) Table 47. China Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2019-2020) Table 48. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) (Million US$) Table 49. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2015-2020) Table 50. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) (Million US$) Table 51. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2015-2020) Table 52. Japan Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (2019-2020) (Million US$) Table 53. Japan Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2019-2020) Table 54. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) (Million US$) Table 55. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2015-2020) Table 56. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) (Million US$) Table 57. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2015-2020) Table 58. Southeast Asia Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (2019-2020) (Million US$) Table 59. Southeast Asia Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2019-2020) Table 60. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) (Million US$) Table 61. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2015-2020) Table 62. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) (Million US$) Table 63. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2015-2020) Table 64. India Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (2019-2020) (Million US$) Table 65. India Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2019-2020) Table 66. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) (Million US$) Table 67. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2015-2020) Table 68. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) (Million US$) Table 69. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2015-2020) Table 70. Central & South America Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (2019-2020) (Million US$) Table 71. Central & South America Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2019-2020) Table 72. Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) (Million US$) Table 73. Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2015-2020) Table 74. Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) (Million US$) Table 75. Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2015-2020) Table 76. Amgen Inc. Company Details Table 77. Amgen Inc. Business Overview Table 78. Amgen Inc. Product Table 79. Amgen Inc. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) (Million US$) Table 80. Amgen Inc. Recent Development Table 81. AstraZeneca Plc Company Details Table 82. AstraZeneca Plc Business Overview Table 83. AstraZeneca Plc Product Table 84. AstraZeneca Plc Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) (Million US$) Table 85. AstraZeneca Plc Recent Development Table 86. Eli Lilly and Co. Company Details Table 87. Eli Lilly and Co. Business Overview Table 88. Eli Lilly and Co. Product Table 89. Eli Lilly and Co. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) (Million US$) Table 90. Eli Lilly and Co. Recent Development Table 91. F. Hoffmann-La Roche Ltd. Company Details Table 92. F. Hoffmann-La Roche Ltd. Business Overview Table 93. F. Hoffmann-La Roche Ltd. Product Table 94. F. Hoffmann-La Roche Ltd. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) (Million US$) Table 95. F. Hoffmann-La Roche Ltd. Recent Development Table 96. Novartis AG Company Details Table 97. Novartis AG Business Overview Table 98. Novartis AG Product Table 99. Novartis AG Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) (Million US$) Table 100. Novartis AG Recent Development Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type: 2020 VS 2026 Figure 2. Lung Cancer Features Figure 3. Colorectal Cancer Features Figure 4. Breast Cancer Features Figure 5. Others Features Figure 6. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application: 2020 VS 2026 Figure 7. Hospital Case Studies Figure 8. Research Institutes and Research Institutions Case Studies Figure 9. Clinic Case Studies Figure 10. Other Case Studies Figure 11. Epidermal Growth Factor Receptor (EGFR) Inhibitor Report Years Considered Figure 12. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Regions: 2020 VS 2026 Figure 14. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Players in 2019 Figure 17. Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in 2019 Figure 19. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Amgen Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Amgen Inc. Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) Figure 28. AstraZeneca Plc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. AstraZeneca Plc Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) Figure 30. Eli Lilly and Co. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Eli Lilly and Co. Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) Figure 32. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) Figure 34. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Novartis AG Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) Figure 36. Bottom-up and Top-down Approaches for This Report Figure 37. Data Triangulation Figure 38. Key Executives Interviewed

Amgen Inc. AstraZeneca Plc Eli Lilly and Co. F. Hoffmann-La Roche Ltd. Novartis AG